Abstract:A 48-year-old woman presented with a 50-day history of irregular vaginal bleeding and lower abdominal pain. Ultrasound indicated an extremely large occupying lesion in the pelvic cavity that was highly suggestive of malignancy. Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) was performed to further assess the nature of pelvic abnormality. PET/CT images demonstrated a diffusely lobulated mass ranging from cervix up to the inferior pole of kidneys with mild FDG uptake. Simulta… Show more
“…It was first described by Birch-Hirschfeld in 1896 [3] while IVL with the cardiac extension was first reported in 1907 by Dürck [2,4]. An extrauterine leiomyoma occurs in 30% of cases and IVL with the cardiac extension has been reported in approximately 10% of cases [1]. In 2015, Fornaris et al [2] reported a case of IVL with extension to the pulmonary artery.…”
Section: Discussionmentioning
confidence: 99%
“…An IVL is a rare [1] and potentially life-threatening tumor [2]. It was first described by Birch-Hirschfeld in 1896 [3] while IVL with the cardiac extension was first reported in 1907 by Dürck [2,4].…”
Section: Discussionmentioning
confidence: 99%
“…Intravenous leiomyomatosis (IVL) is a benign smooth muscle cell tumor of uterine origin. The tumor can extend through the pelvic veins, renal veins and inferior vena cava (IVC) into the right atrium (RA) or as far as the pulmonary artery [1]. IVL can cause dyspnea, chest pain, heart failure and sudden death [2,3].…”
We report a case of intravenous leiomyomatosis with right atrium extension through the left gonadal vein, left renal vein and inferior vena cava. The tumor moved in and out of the right ventricle via the tricuspid valve, which could lead to valve obstruction and sudden death. We illustrate the importance of multimodality cardiac imaging to diagnose this condition by performing echocardiography, cardiac magnetic resonance imaging and computed tomography.
“…It was first described by Birch-Hirschfeld in 1896 [3] while IVL with the cardiac extension was first reported in 1907 by Dürck [2,4]. An extrauterine leiomyoma occurs in 30% of cases and IVL with the cardiac extension has been reported in approximately 10% of cases [1]. In 2015, Fornaris et al [2] reported a case of IVL with extension to the pulmonary artery.…”
Section: Discussionmentioning
confidence: 99%
“…An IVL is a rare [1] and potentially life-threatening tumor [2]. It was first described by Birch-Hirschfeld in 1896 [3] while IVL with the cardiac extension was first reported in 1907 by Dürck [2,4].…”
Section: Discussionmentioning
confidence: 99%
“…Intravenous leiomyomatosis (IVL) is a benign smooth muscle cell tumor of uterine origin. The tumor can extend through the pelvic veins, renal veins and inferior vena cava (IVC) into the right atrium (RA) or as far as the pulmonary artery [1]. IVL can cause dyspnea, chest pain, heart failure and sudden death [2,3].…”
We report a case of intravenous leiomyomatosis with right atrium extension through the left gonadal vein, left renal vein and inferior vena cava. The tumor moved in and out of the right ventricle via the tricuspid valve, which could lead to valve obstruction and sudden death. We illustrate the importance of multimodality cardiac imaging to diagnose this condition by performing echocardiography, cardiac magnetic resonance imaging and computed tomography.
“…Although all three entities are rare, intravenous extension into the heart is the most common, with more than 100 reported cases since the early 1900s [2], and the least reported type is benign metastasizing leiomyoma It is not excluded, without being proven, that their physiopathology is common [14,15]. Furthermore, it is necessary to confirm the diagnosis by histological examination in order to rule out the differential diagnosis of leiomyosarcoma, which may have the same clinical characteristics as benign metastatic leiomyoma [16][17]. To the best of our knowledge, there are only four prior case reports of benign metastasizing leiomyoma to the heart (Table 1) [1,3,4].…”
Cardiac smooth muscle tumors are rare; three different clinical settings for these tumors have been reported, including benign metastasizing leiomyoma from the uterus, primary cardiac leiomyoma and leiomyosarcoma, and intravenous cardiac extension of pelvic leiomyoma, which is the most common. We present a case of a 56-year-old woman with a benign metastasizing leiomyoma to the heart without associated pulmonary localization 15 years after endoscopic vaginal myomectomy of polymyomatous uterus. Immunohistochemical stains for H-Caldesmon, Desmin, and estrogen, progesterone receptors were positive, indicating a smooth muscle tumor of uterine origin. To our knowledge, this is only the fifth reported case of benign metastasizing leiomyoma to the heart with histological proof and the first case of earlier onset cardiac metastasis without pulmonary metastasis localization. It illustrates that benign metastasizing leiomyoma should be included in the differential diagnosis of cardiac tumors in patients with a history of surgery uterine leiomyoma perfectly benign.
“…Although IVL is histologically benign, the tumor has the potential to be clinically aggressive due to its massive intraluminal growth. In most cases, IVL is limited to the pelvic veins, and in rare instances, may extend through the inferior vena cava (IVC) to the right heart chambers (causing intracardiac leiomyomatosis (ICL) (2). Further intracardiac spread into the main pulmonary artery is potentially life-threatening.…”
Introduction: To summarize the vascular ultrasonographic features of intravenous leiomyomatosis (IVL) and assess the role of this method for the accurate diagnosis of patients with IVL. The current study was carried out in Shandong provincial hospital affiliated to Shandong university and Shandong medical imaging research institute, Shandong university of Jinan, Shandong province, P.R. China in 2017. Case Presentation: The 9 samples of IVL were collected from patients undergone surgery from July 2007 to December 2016 in the department of gynecology of the hospital. The clinical data, vascular ultrasonographic findings, and histologic results were retrospectively reviewed. Six patients underwent computed tomography (CT) and 3 patients were examined by magnetic resonance imaging (MRI). Clinical symptoms included lower extremity edema, chest congestion, and syncope. Any pelvic masses found were identified. On ultrasonography, the internal iliac vein, common iliac vein, and the inferior vena cava (IVC) were all involved with dilated veins and isoechoic masses noted in all 9 patients. The right ovarian vein was involved in 2 patients, and in 3 patients, masses had emerged in the IVC and spread into the right atrium, at times intruding into the tricuspid orifice during diastole. All 9 patients underwent a 1-stage thoracoabdominal surgical procedure. There was no documented recurrence of the masses in 7 patients and in the remaining 2 patients; solid pelvic masses were detected 3 or 6 months after the surgery. No intravascular masses were detected. Conclusions: Ultrasonography is performed to evaluate the features and path of extension of IVL. Patients diagnosed with uterine leiomyoma or hysterectomy were at greater risk of developing IVL. Vascular ultrasound could be used as an additional diagnostic tool for IVL screening and diagnosis in patients at an early age.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.